CIPHER PHARMACEUTICALS SCHEDULES Q3 2022 EARNINGS RELEASE AND CONFERENCE CALL
26 Oktober 2022 - 1:00PM
PR Newswire (Canada)
OAKVILLE, ON, Oct. 26,
2022 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: CPH)
("Cipher" or "the Company") today announced that it
will release its Q3 2022 financial results on Thursday, November 10, 2022 after market close.
The company will hold a conference call on Friday, November 11, 2022 at 8:30am ET to discuss the results and corporate
developments.
CONFERENCE CALL DETAILS
DATE:
|
Friday, November 11,
2022
|
TIME:
|
8:30 a.m.
EDT
|
DIAL-IN NUMBER:
|
(416) 764-8650 or (888)
664-6383
|
CONFERENCE ID:
|
59484713
|
REPLAY DIAL-IN:
|
(888) 390-0541
(playback 484713#)
Expires November 18, 2022
|
WEBCAST:
|
https://app.webinar.net/ApnV68m4x1k
|
About Cipher Pharmaceuticals
Inc.
Cipher Pharmaceuticals (TSX: CPH) is a specialty pharmaceutical
company with a robust and diversified portfolio of commercial and
early to late-stage products. Cipher acquires products that fulfill
unmet medical needs, manages the required clinical development and
regulatory approval process, and currently markets those products
either directly in Canada or indirectly through partners
in Canada, the U.S., and South America. For more
information, visit www.cipherpharma.com.
SOURCE Cipher Pharmaceuticals Inc.
Copyright 2022 Canada NewsWire
Cipher Pharmaceuticals (TSX:CPH)
Historical Stock Chart
Von Aug 2024 bis Sep 2024
Cipher Pharmaceuticals (TSX:CPH)
Historical Stock Chart
Von Sep 2023 bis Sep 2024